People: Furiex Pharmaceuticals Inc (FURX.O)
12 Dec 2013
Dr. Wendy L. Dixon, Ph.D. is Independent Director of Furiex Pharmaceuticals Inc. She is a Senior Advisor to The Monitor Group, a worldwide consulting firm. She has had an over 30-year career in the pharmaceutical and biotechnology business, combining a technical background and experience in drug development and regulatory affairs with commercial responsibilities in building and organizations and launching and growing more than 20 pharmaceutical products including Tagamet, Fosamax, Singulair, Plavix, Abilify, Reyataz and Baraclude. From 2001 to 2009 she was Chief Marketing Officer and President, Global Marketing for Bristol-Myers Squibb, and served on the CEO’s Executive Committee. From 1996 to 2001 she was Senior Vice President Marketing at Merck and prior to that she held executive management positions at West Pharmaceuticals, Osteotech and Centocor, and various positions at SmithKline and French (now GlaxoSmithKline) in marketing, regulatory affairs, project management and as a biochemist. Dr. Dixon serves on the boards of directors of Alkermes, Inc., Ardea Biosciences, Inc., Incyte Corporation and Orexigen Therapeutics, Inc.
|Total Annual Compensation,||Long-Term Incentive Plans,||All Other,||Fiscal Year Total,|